Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...

A former Pfizer Inc. scientist denied an allegation made by House Republicans that he conspired to delay the release of Covid ...

After resolving a patent dispute with Incyte, Sun Pharma has officially launched its JAK inhibitor Leqselvi in the U.S. | Sun ...

Explore last week's key healthcare market trends, top gainers & losers, major deals, Trump's tariff plans, FDA approvals, and significant legal updates.

Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 ...

Pfizer (PFE) and BioNTech (BNTX) challenge Moderna's patent win in London court over mRNA COVID-19 vaccine technology. Read ...

Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...

Korea has developed the world's first recombinant protein-based anthrax vaccine, a major step toward self-sufficiency that ...

Get the latest stock analysis from Benzinga? This article Lawmakers Investigate Whether Pfizer Delayed COVID-19 Vaccine Results For Political Reasons originally appeared on Benzinga.com ...

House Judiciary subpoenas ex-Pfizer exec Philip Dormitzer amid claims the COVID-19 vaccine announcement was delayed to avoid influencing the 2020 election.

BioNTech has announced the acquisition of fellow German biotech CureVac in an all-stock transaction valued at approximately ...

The House Judiciary Committee has subpoenaed Philip Dormitzer, a former Pfizer executive, over claims that the company delayed announcing favorable COVID-19 vaccine trial results until after the ...